NCT04905056View on ClinicalTrials.gov

A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Progression
Interventions
OTHER

Ablation therapy

Ablation therapy in the treatment of lung cancer presenting as ground-glass nodules

Trial Locations (1)

200032

RECRUITING

Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER